Form 4/A · Filed Jun 3, 2026, 01:49 AM UTC
AURX/Nuo Therapeutics, Inc.
Pittman Scott M. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 23, 2026 | A | other | 30,050 | — | — | 30,050 |
| Jan 23, 2026 | A | other | 36,750 | — | — | 0 |
| Jan 23, 2026 | A | other | 7,516 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001437749-26-019244